Treatment of MS with Copaxone and Albuterol (AMS01)
收藏NIAID Data Ecosystem2026-05-10 收录
数据链接：
官方服务：
资源简介：
A randomized, double-masked, 2-arm pilot study of Copaxone and albuterol versus Copaxone and placebo for the treatment of multiple sclerosis. Twenty-four patients with MS who meet the inclusion/exclusion criteria will be enrolled per arm. Each patient will be randomized to receive either 20 mg SQ of Copaxone plus an oral dose of placebo daily or 20 mg SQ of Copaxone plus an oral dose of albuterol daily. Patients will be followed for two years.
创建时间：
2025-10-30
